Healthcare -
Biotechnology - NASDAQ - US
$ 13.55
0 %
$ 196 M
Market Cap
0.11
P/E
INBX - GROSS PROFIT
Gross Profit INBX - Inhibrx Biosciences, Inc.
609 K
LAST VALUE
-62.95%
2 YEAR CAGR
15.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR